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ABSTRACT
Introduction: Plasmodium knowlesi has long been
present in Malaysia, and is now an emerging cause of
zoonotic human malaria. Cases have been confirmed
throughout South-East Asia where the ranges of its
natural macaque hosts and Anopheles leucosphyrus
group vectors overlap. The majority of cases are from
Eastern Malaysia, with increasing total public health
notifications despite a concurrent reduction in
Plasmodium falciparum and P. vivax malaria.
The public health implications are concerning given
P. knowlesi has the highest risk of severe and fatal
disease of all Plasmodium spp in Malaysia. Current
patterns of risk and disease vary based on vector type
and competence, with individual exposure risks related
to forest and forest-edge activities still poorly defined.
Clustering of cases has not yet been systematically
evaluated despite reports of peri-domestic
transmission and known vector competence for
human-to-human transmission.
Methods and analysis: A population-based case–
control study will be conducted over a 2-year period
at two adjacent districts in north-west Sabah,
Malaysia. Confirmed malaria cases presenting to the
district hospital sites meeting relevant inclusion
criteria will be requested to enrol. Three community
controls matched to the same village as the case will
be selected randomly. Study procedures will include
blood sampling and administration of household and
individual questionnaires to evaluate potential
exposure risks associated with acquisition of P.
knowlesi malaria. Secondary outcomes will include
differences in exposure variables between P. knowlesi
and other Plasmodium spp, risk of severe P. knowlesi
malaria, and evaluation of P. knowlesi case clustering.
Primary analysis will be per protocol, with adjusted
ORs for exposure risks between cases and controls
calculated using conditional multiple logistic
regression models.
Ethics: This study has been approved by the
human research ethics committees of Malaysia,
the Menzies School of Health Research, Australia,
and the London School of Hygiene and Tropical
Medicine, UK.
INTRODUCTION
Plasmodium knowlesi as an emerging public
health problem in Malaysia
The ﬁrst naturally acquired human infection
of the simian malaria parasite Plasmodium
knowlesi was reported in 1965 in Pahang,
Peninsular Malaysia.1 A survey of 1117
people living in the vicinity of the case failed
to produce further evidence of P. knowlesi
human infection.2 Subsequent screening for
Strengths and limitations of this study
▪ This study design will allow identification of
Plasmodium knowlesi malaria risk factors, at-risk
groups and case clustering, while controlling for
the large number of human exposure variables
related to complex monkey host and mosquito
vector transmission dynamics.
▪ As P. knowlesi malaria can be acquired by all
demographics, the selection of community con-
trols allows extrapolation of exposure variables
to the true population at risk, and will help to
guide future public health strategies for human
P. knowlesi malaria throughout the region.
▪ While potential bias in selecting community controls
does exist by assuming all cases have the same
access to the district hospital referral and enrolment
site, this is minimised by standard Malaysian
Ministry of Health malaria health policies.
▪ Controls matched to the same village as the
case, who have lived there over the same preced-
ing time period, will allow delineation of microe-
pidemiological risk exposures on an individual
and household level and will also assist in mini-
mising bias related to differences in case acces-
sibility to the enrolment sites.
▪ Not matching controls to the case’s age and
gender gives less power to detect differences in
other individual exposure risks within these
demographics; however, it does allow analysis of
these as potential independent risk factors,
including their relationship with disease severity.
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P. knowlesi was limited due to the assumed scarcity of zoo-
notic human malaria and an inability to differentiate
morphologically between P. knowlesi and P. malariae using
routine microscopy.3 4 In 2004, atypical P. malariae
microscopy reported cases were correctly identiﬁed by
PCR as a substantial focus of human P. knowlesi infec-
tions at Kapit in Sarawak, Eastern Malaysia.5 P. knowlesi is
also commonly misreported by microscopy as either
P. falciparum or P. vivax in endemic areas such as Sabah,
Malaysia,4 6 where state guidelines currently only require
routine referral of microscopic P. malariae cases for con-
ﬁrmatory PCR speciation.7
Current evidence suggests that P. knowlesi has long
been present in Eastern Malaysia.6 8 9 Analysis of P. know-
lesi mtDNA sequences from Sarawak suggest that P. know-
lesi was present in local macaques before the arrival of
humans in South-East Asia10 and a large increase in the
parasite population corresponds to the initial rise in the
human population in this region around 30 000–40 000
years ago.11 The earliest PCR conﬁrmation of P. knowlesi
comes from archival slides from Sarawak (originally diag-
nosed as P. malariae) dating back to 1996.12 Recent
studies in Eastern Malaysia have consistently shown that
only a very small proportion (<1%) of P. malariae cases
diagnosed by microscopy can be conﬁrmed by PCR. The
vast majority of these cases are, in fact, P. knowlesi.5 8 13–17
By extension it is possible that a signiﬁcant proportion
of P. malariae cases reported historically in Eastern
Malaysia were, in reality, P. knowlesi infections. The earli-
est malaria surveys conducted in Tambunan, Sabah,
between 1939 and 1942 described high-intensity malaria
foci in hilly ravines with unconﬁrmed P. malariae.18 In
Sarawak, results from the ﬁrst recorded microscopy-
based surveys conducted in 1952 indicated that
P. malariae accounted for 33% of all malaria cases and
up to 76% in some areas.2
In Sabah, recently, a marked, rapid increase in the
number of P. knowlesi cases beginning in the south-west
and progressing north-easterly has been reported.19
Public health microscopy notiﬁcations for P. knowlesi in
Sabah (including those reported as P. malariae) have
increased from around 2% (59/2741) of all malaria
cases in 2004, to 35% (703/1936) in 201119 and,
recently, to 62% in 2013 (996/1606) (Sabah
Department of Health, unpublished). The rise in
P. knowlesi notiﬁcations in Sabah may also be underesti-
mated given PCR-conﬁrmed P. knowlesi is misdiagnosed
as P. falciparum or P. vivax in up to 13% and 10% of
cases, respectively, by routine microscopic examination
in this area.4 In Sarawak, government health reports of
P. knowlesi or P. malariae microscopy notiﬁcations totalled
14.3% (1731/12 082) of all malaria cases between 2000
and 2006,9 increasing to 41% (897/2189) in 200915 and
to 73% (737/1004) in 2013.20 The change in
Plasmodium spp proportions in both Sabah and Sarawak
coincides with an effective national Malaria Control
Program implemented in Eastern Malaysia in 1971,21
with a consequent decrease in P. falciparum and P. vivax
cases.19 However, this does not explain the differences
in transmission dynamics that have resulted in a marked
increase in absolute numbers of P. knowlesi cases in
Sabah but not in Sarawak.
Since 2004, sporadic cases of PCR-conﬁrmed P. know-
lesi human malaria have also been reported in
Peninsular Malaysia and a number of Asian countries
including Thailand, Vietnam, Cambodia, Myanmar,
Singapore, Brunei, Indonesia, India, China and the
Philippines.8 22–30 Recent risk maps suggest that large
areas in this region have the necessary pre-requisites for
an infectious P. knowlesi reservoir31 and as molecular
diagnosis is not routine outside Malaysia, it is possible
that a substantial number of P. knowlesi infections are
going undetected. However, existing evidence also sug-
gests that P. knowlesi incidence is relatively low in areas
where other human Plasmodium spp predominate.23 32
Outside Malaysia, P. knowlesi occurs most commonly
within mixed infections23 27 33 and has not yet been
shown to cause severe disease. In Malaysia, by contrast,
P. knowlesi is associated with a threefold risk of severe
disease compared with P. falciparum17 and fatal outcomes
have been reported.34 35
Current understanding on epidemiological patterns of
P. knowlesi risk
Currently it is unclear why patterns of P. knowlesi infec-
tion and disease in at-risk populations vary so markedly
across this region. Overall, the distribution of cases is
constrained by the ranges of the predominant natural
hosts for P. knowlesi: long-tailed (Macaca fascicularis) and
pig-tailed (M. nemestrina) macaques.36 Transmission also
depends on the presence of competent mosquito
vectors within the Anopheles leucosphyrus group,37 which,
together with factors that determine the nature of
vector-human contact, results in a spatially heteroge-
neous pattern of P. knowlesi transmission and more fun-
damental variations in the epidemiology of the disease.
In Kapit, Sarawak, for example, A. leucosphyrus (previ-
ously described as A. latens) was identiﬁed in 2006 as a
P. knowlesi vector of both humans and monkeys and
demonstrated relatively high human biting rates within a
farming area at the forest fringe.38 These entomological
ﬁndings were consistent with results from an epidemio-
logical study carried out at Kapit Hospital in 2006–2008,
during which 87% (93/107) of patients who were pro-
spectively admitted with P. knowlesi malaria reported
having engaged in recent undeﬁned forest or forest-
edge activities.39 The epidemiological picture in Sabah,
where Anopheles balabacensis (the vector used in human
P. knowlesi transmission studies in the 1960s40) is
assumed to be the main vector for P. knowlesi,41 42 is
hypothesised to be different. However, a prospective
study of malaria patients from a referral catchment area
of north-western Sabah also described 92% (119/130)
of PCR conﬁrmed P. knowlesi malaria cases having forest
or plantation exposure. Despite this, patients with
P. knowlesi in this study were no more likely than patients
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with P. falciparum to report staying overnight or spending
>4 h in a forest or plantation in the previous 1 month.17
In contrast, living within a 20 min walk of unclassiﬁed
forest type or a plantation did appear related (p=0.001
and 0.015, respectively), in addition to a positive history
of sighting a monkey in the previous 4 weeks
(p<0.001).17
While comparisons in P. knowlesi transmission patterns
between Sabah and Sarawak remain difﬁcult given broad
deﬁnitions of forest and forest-edge exposure in previ-
ous studies, differences in more speciﬁc related factors
may be impacting on the patterns of clustering of
P. knowlesi cases. Initial studies from Sarawak had shown
a higher prevalence of P. knowlesi malaria in adult males
with occupational forest exposure, with no clustering of
cases despite the fact that most people live in communal
longhouses.5 Data from Sabah have also documented up
to 78% of P. knowlesi cases are male17 19 while for female
cases a bimodal age distribution was described, which
may still indicate that risk of infection is predominantly
linked to exposure activities.19 In addition, no relation-
ship with occupation was seen when comparing P. know-
lesi with P. falciparum cases.17 19 However, a study at
Kudat at the north-western tip of Sabah showed clear dif-
ferences to Sarawak with both a wide age distribution of
cases and contemporaneous family clusters including
children and town residents, suggesting peridomestic
transmission is also occurring.43 P. knowlesi cases in
Sabah have also been shown to demonstrate temporal
clustering, with marked seasonality (p<0.001) associated
with a peak of cases in May and 3–5 months post-high
rainfall.19 43
Evidence of peridomestic transmission in Sabah raises
the possibility of human-to-human transmission. To date,
this is not evident from focused studies outside Sabah
where macaque and human samples have been com-
pared. These include the analysis of P. knowlesi CSP or
MSP gene sequences in Sarawak and Peninsular
Malaysia, and also in other countries including
Singapore and Thailand, which all showed a large
number of shared haplotypes that were similarly diverse
in both hosts, supporting a zoonotic rather than exclu-
sively human transmission mode.10 32 44 45 In addition,
no evidence of ongoing human P. knowlesi transmission
in areas without a macaque reservoir has been documen-
ted. However, in the absence of large-scale molecular
studies comparing humans and macaques in this region,
and given human-to-human transmission has been
demonstrated under experimental conditions,40 the
occurrence of natural human-to-human P. knowlesi trans-
mission alongside monkey-to-human transmission
remains possible.
Key knowledge gaps in epidemiological determinants
of P. knowlesi risk
P. knowlesi acquisition risk factors related to behaviour or
environment currently remain poorly deﬁned even in
the more intensively studied areas of Eastern Malaysia.
Changes in land use such as shifts in agricultural prac-
tices, deforestation and forest fragmentation have been
proposed as key drivers in the emergence of P. knowlesi
infection.8 However, there has been no detailed evalu-
ation of potential risk factors related to household
characteristics or local patterns of land use/land cover.
In addition, there is limited understanding of human
movement patterns or travel history related to differ-
ences in forest or forest edge exposure, including dur-
ation, frequency and timing of activities. Occupational
exposure has not been evaluated in a systematic manner,
either with respect to seasonal practices or differences
associated with rubber or palm oil plantations versus
traditional freeholder farming. To date, no studies have
looked in detail at human and monkey interaction, con-
sidering the zoonotic transmission mode of P. knowlesi
and the potential novel risks related to encroachment of
humans on macaque habitats and vice versa. This inter-
action could relate to proximity of vectors and include
conﬂict around availability of food for macaques from
human agricultural practices such as cultivated fruit
orchards, rice paddies or cornﬁelds, in addition to trad-
itional or changing practices such as trapping or
hunting monkeys for pets or food.
Current reported studies have not been designed to
control for other human behavioural or immunological
factors such as the documented higher incidence of
P. knowlesi malaria in older age17 39 43 46 or the risk of
P. knowlesi malaria during pregnancy. Age as a demo-
graphic factor alone also needs investigation, given wide-
spread reports of P. knowlesi cases in children in Malaysia
and elsewhere in South-East Asia.23 46 47 In addition, no
studies have evaluated whether genetic factors affect
individual P. knowlesi malaria acquisition risk, such as
seen with the protective nature of certain human red
blood cell polymorphisms against other Plasmodium
spp.48–50
Case–control study designs to identify risk factors
for malaria
Case–control study designs have been used in areas of
low endemicity in the past to identify risk factors for
malaria due to other Plasmodium spp.51 Existing efforts
to ﬁll knowledge gaps in individual risk for human
P. knowlesi malaria focus on delineating activities at the
forest edge and within the forest, and differentiating
these in terms of occupational risk and those related to
domestic behaviour. As the current incidence of
P. knowlesi malaria in Sabah is relatively low, a prospective
cohort study design would not be an efﬁcient way of
assessing these relative risks because of the very large
number of participants that would need to be recruited.
In addition, with a cohort study the loss to follow-up of
any participants would negatively impact the causal ana-
lysis of the primary outcome of interest, which is the
acquisition of P. knowlesi malaria. The case–control
design is also particularly well suited in identifying
at-risk groups or clustering at a ﬁner epidemiological
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scale as it allows controlling for the complex and large
number of human exposure variables involved in the
transmission dynamics of P. knowlesi infection. In add-
ition, this design is useful for generating hypotheses on
P. knowlesi acquisition that can be tested using other
future study designs such as cross-sectional surveys,
which are more suited to providing detailed information
on population-wide P. knowlesi prevalence including
asymptomatic infection.
AIM AND OBJECTIVES
The study design described in this protocol will allow
evaluation of the primary research question: “Which
factors lead to increased risk of acquiring human
P. knowlesi malaria in Sabah, Malaysia?” Secondary objec-
tives will include comparisons of malaria acquisition risk
between different Plasmodium spp, risk of severe disease
within the P. knowlesi group of malaria cases, and evalu-
ation of P. knowlesi clustering.
Information resulting from this study will assist in
guiding public health strategies for malaria in this
region and provide valuable human epidemiological
data for integration with concurrent studies on the ento-
mology, primatology and land use aspects of P. knowlesi
transmission (Monkeybar project: UK MRC ESEI Grant
#G1100796) and the clinical treatment of P. knowlesi
malaria (clinicaltrials.gov #NCT01708876).
METHODS AND ANALYSIS
Current status: Enrolment started in December 2012, with
189 P. knowlesi cases and 564 community controls as on
June 2014.
Study design
This will be a population-based case–control study con-
ducted in two adjacent districts: Kudat and Kota Marudu
in the state of Sabah, Malaysian Borneo (ﬁgure 1).
Within the study sites, all malaria cases, regardless of
parasite species, meeting speciﬁed inclusion criteria will
be enrolled at the corresponding district referral hos-
pital over a 2-year period. Research ﬁeldworkers will go
to the village of the case within 2 weeks of focal case
detection and randomly select three community controls
who have primarily resided in the village for the past
3 weeks. This will enable matching of the controls with
the case by the same geographical area (local village)
and preceding minimum time period of exposure risk
(3 weeks).
Study sites
Kudat and Kota Murudu districts cover an area of
3204 km2 over the north-western tip of the state of
Sabah, Malaysian Borneo and have a combined popula-
tion of around 150 000 (2010 data52). These sites were
chosen predominantly because of documented high
incidence of P. knowlesi infection; in particular with
P. knowlesi being the predominant species in Kudat.43 46
Kudat and Kota Murudu districts have central referral
hospitals serving deﬁned catchment areas with large out-
patient and inpatient facilities. Recruitment was also
expanded to include patients presenting primarily to
Kota Marudu District Hospital from the neighbouring
Pitas district, with a higher proportion of cases due to
other Plasmodium spp enabling secondary objectives to
be evaluated.
Community controls
Because P. knowlesi can be acquired by either sex and at
any age,34 39 43 46 community controls can provide an
accurate representation of the study base population.
This enables extrapolation of explored variables to the
true population at risk.53 Choosing controls with no
history of fever minimises possible confounding from any
concurrent acute illness. By not choosing hospital con-
trols there is some bias generated in assuming controls
enrolled out in the community have the same access to
the hospital study site as cases. The choice of community
controls may also create bias by assuming that the malaria
cases that present to the hospital and are enrolled genu-
inely account for all malaria cases in the community, that
is, the study base population. However, in the current
setting, factors that increase the likelihood of ascertain-
ing all cases include (1) mandatory state reporting and
hospital referral of malaria cases from government and
private clinics; (2) the presence of only a single district
referral hospital in each of the two study sites and (3) the
provision of free or relatively inexpensive treatment at
government health facilities. State Ministry of Health
guidelines also dictate that a blood ﬁlm for malaria
should be prepared routinely for any patient who pre-
sents to a government health facility with fever.
Matching controls to the case’s home village
This further minimises case ascertainment bias related
to variations in geographical accessibility to the main
referral study site. Matched village controls may reside
anywhere within the study districts, whereas hospital con-
trols may potentially come from a more restricted geo-
graphical area around the hospital. This design also
provides greater statistical power to evaluate microepide-
miological features related to individual and household
factors. This was deemed more important than a design
using hospital controls, which would have enabled com-
parisons between different locations and villages, but
which would have had less power to delineate individual
behaviour and demographic exposure risks.
Matching controls for preceding time exposure
Controls will be enrolled within a 2-week time period fol-
lowing identiﬁcation of the case. Only individuals who
have resided in the study area over a 3-week period prior
to the presentation of the matched case will be eligible.
This will encompass the prepatent time period of
P. knowlesi infection of around 9–12 days.40 Analysis of
potential relationships that vary over time such as
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seasonal planting or harvesting, other agricultural prac-
tices, cultural events or meteorological data will be
possible.
Non-matching controls for age/gender
While this would have given additional power to detect
differences in exposure risks within these demographics,
it was decided that age and gender should be evaluated
as potential independent risk factors. This will also allow
comparisons between Plasmodium spp and with disease
severity related to age or gender.
Recruitment/sample size
We aim to recruit all cases of conﬁrmed malaria of any
species or severity over the study duration from Kudat
and Kota Murudu district hospitals. On the basis of
current recruitment rates of around 10 malaria cases per
month over the last year from both sites, we expect to
enrol approximately 240 cases of P. knowlesi malaria and
an additional 90 cases of malaria due to other species in
the period December 2012 to December 2014. For the
330 malaria cases we will recruit 990 matched controls.
A recruitment logbook will be kept for all screened cases
and controls to document reasons for non-eligibility,
which will be included in the analysis. With three con-
trols per case, assuming probability of exposure among
controls (Po) is 0.1, and the relative risk (RR) of
acquiring P. knowlesi malaria in exposed subjects relative
to unexposed subjects is 0.3, we will need to study a
minimum of 210 P. knowlesi cases to be able to reject the
null hypothesis that there is no difference between cases
and controls (ie, relative risk=1), with 80% power and an
α level of 0.05.54
Definition and selection of cases
All male or female patients of any age presenting to a
study site with conﬁrmed malaria.
Inclusion criteria: Positive microscopy for Plasmodium
infection; documented fever or history of fever in the
past 48 h; primarily resided in the study area in the pre-
vious 3 weeks; residence can be located and mapped;
appropriate informed consent obtained.
Exclusion criteria: Previously enrolled as a case (repeat
malaria infection); age <4 weeks; subsequent PCR nega-
tive for Plasmodium spp monoinfection.
Cases will be classiﬁed according to PCR conﬁrmation
of Plasmodium spp monoinfection. Severe and non-severe
P. knowlesi cases will be deﬁned by whether they meet
modiﬁed WHO 2010 severe malaria clinical and labora-
tory criteria as described elsewhere.17
Definition and selection of community controls
A systematic selection procedure will be used to recruit
three community controls for each case matched to the
Figure 1 Map of study sites.
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same village. This number of controls was chosen to
provide sufﬁcient statistical power to measure exposure
effects, while at the same time making the recruitment
process feasible logistically. Selection of control house-
holds and individuals within these households will be
conducted using a validated and pretested random
method based on up-to-date Malaysian Public Health
Department village maps and household lists.
Corroboration of the number of households will be
undertaken with local residents, public health ofﬁcers
and village heads, where available. Households will be
numbered using either the map and/or the household
head of family name. A smartphone application gener-
ates a random number corresponding to one of the
households. Individuals primarily residing within the
selected household in the previous 3 weeks will be num-
bered and then randomised by the same application. All
households within the village and all individuals within
that household will have an equal chance of being
selected. If the selected individual is not present when
the ﬁeldworkers visit the household, then they will
return up to three times, which may include an
arranged later time on the same day or on subsequent
days. This will minimise selection bias related to the
higher likelihood of male adults or school age children
not being present at the household during the day. If it
is not possible to obtain informed consent from a
selected individual or if the speciﬁed inclusion criteria
are not met, another individual within the same house
will be selected based on the next randomly generated
number. Failing this an alternative household will be
selected using the same method.
Control inclusion criteria: Appropriate informed consent
obtained; agree to ﬁnger-prick blood sample; negative
blood slide and PCR result for malaria (delayed); pri-
marily resided in the study area in preceding 3 weeks;
residence can be located and mapped; no history of
fever in previous 48 h.
Control exclusion criteria: Previously recruited as a case;
previously recruited as a control; member of a previously
selected control household; age<4 weeks.
Study procedures
Follow-up
Both cases and controls will require a single visit to their
homes to administer the questionnaire and household
survey and to carry out blood sampling and GPS
mapping. This will occur within a 2-week period after
the index case detection (see ﬁgure 2).
Questionnaire
A standardised pretested questionnaire was developed
with input from multiple relevant disciplines including
public health, epidemiology, clinical, entomology, primat-
ology and social science. The questionnaire will be admi-
nistered to cases and controls by trained ﬁeldworkers
who are native speakers in Bahasa Malaysia or other local
dialects. The questions will elicit possible associations of
malaria with several categories of potential environmen-
tal, socioeconomic and clinical risk factors, particularly in
the context of potential interaction with primate hosts
and vectors. Owing to the nature of case and control
recruitment it will not be possible to blind ﬁeldworkers to
the participant’s recent malaria status. For children or
younger participants who are either not able or are
uncomfortable answering the questions, the household
head or parent/guardian will be asked to answer from
the participant’s perspective. Participants who do not
speak Bahasa Malaysia or other local dialects, or who are
unable to answer the questions for other reasons, will
have an appropriate family member answer for them.
Household survey
Fieldworkers will conduct a household survey to record
data for a range of variables including household con-
struction and utilities, malaria prevention methods used,
ownership of assets, characteristics of the surrounding
environment and other factors relating to potential
monkey and vector exposure. All households will be
mapped using a GPS receiver.
Economic status
An index of socioeconomic status will be derived using
established methods.55 56 The index will incorporate
locally validated surrogate markers of income including
access to services (electricity, water, sanitation) and own-
ership of speciﬁc assets (motorbike, car, refrigerator,
generator or television).
Blood sampling
Blood collection will be requested at time of enrolment
for cases, controls and additional members of control
households. A venepuncture or ﬁnger-prick will be per-
formed for cases and members of control households,
respectively. No additional blood will be collected from
cases already enrolled in parallel clinical studies (which
include all assays required for the case–control study).
Whole blood will be used for preparation of Giemsa
stained thin and thick blood ﬁlms to assess for malarial
parasites, and also collected using 3 ×20 µL spots on
ﬁlter paper (3MM; Whatman, UK) and a 500 µL EDTA
tube (Becton-Dickinson, New Jersey, USA). PCR will be
performed using previously described methods for
P. knowlesi57 and P. falciparum, P. vivax, P. ovale and
P. malariae58 detection. Haemoglobin will be assessed
using a portable spectrophotometer (HemoCue AB,
Angelholm, Sweden) for controls or using standard hos-
pital laboratory methods for cases. Testing for red blood
cell polymorphisms potentially associated with P. knowlesi
acquisition will be performed including glucose-6-
phosphate dehydrogenase (G6PD) deﬁciency, Duffy
antigen receptor for chemokines (DARC) and α and β
thalaessemia. Blood on ﬁlter paper spots will be stored
for potential future serological analysis of historical
changes in exposure to P. knowlesi infection, as has previ-
ously been done for other Plasmodium spp.59
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Statistical plan
Primary
The exposures of interest to be compared between
P. knowlesi malaria cases (PCR-conﬁrmed monoinfection)
and controls will include variables relating to demo-
graphic, behavioural and socioeconomic factors, red
blood cell polymorphisms and serological and immuno-
logical blood markers. Analysis will be per protocol, with
ORs (including 95% CIs) for exposure risk between
cases with P. knowlesi infection and controls calculated by
the Mantel-Haenszel method and then compared.
Confounding variables will be adjusted for using condi-
tional multiple logistic regression models. Normally and
non-normally distributed numerical variables will be ana-
lysed using t tests and Mann-Whitney U tests, respect-
ively. An initial analysis will be conducted for cases and
matched controls with complete variable data sets. The
extent of missing data will be assessed and the sensitivity
of results to alternative approaches to imputing missing
data will be explored, if considered necessary.
Secondary
A similar analytical approach to the above will be used.
Exposures of interest will be compared between all
P. knowlesi and other Plasmodium spp malaria cases, as
well as between severe and non-severe P. knowlesi
malaria. Temporal and spatial patterns of molecularly
conﬁrmed cases will be described and potential correla-
tions with meteorological and other environmental vari-
ables will be explored using data from automatic
weather stations and remote sensing satellites. PCR
assessment of prevalence of asymptomatic parasitaemia
of any species, pregnancy outcomes and burden of
anaemia associated with different malarial parasite
species will also be detailed.
Exclusion/censoring
Any cases found to have subsequent negative PCR for
Plasmodium spp will be excluded in the analysis, while
those with mixed Plasmodium spp infection will be cen-
sored in the analysis. Any controls who are subsequently
shown to have a positive blood ﬁlm or PCR result for
any Plasmodium spp at the time of enrolment will be cen-
sored in the analysis. Data from participants withdrawing
consent will be censored in the analysis after that time-
point. For controls who withdraw, replacements will be
sought as long as it is still possible to meet inclusion
criteria.
Figure 2 Enrolment/study
procedures flow chart.
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ETHICS AND DISSEMINATION
Ethics
The study will adhere to the principles that govern bio-
medical research involving human subjects. The
Declaration of Helsinki will be followed to provide assur-
ance that the rights, integrity and conﬁdentiality of
study subjects are protected and that reported results
are credible and accurate. Written informed consent will
be obtained from participants or parents/guardians if
<18 years of age. Any potential controls or household
members found to have a positive screen for malaria will
be treated as per standard Malaysian Ministry of Health
guidelines. No payments will be made to participants.
This study has been approved by the human research
ethics committees of Malaysia (MREC), the Menzies
School of Health Research, Australia and the London
School of Hygiene and Tropical Medicine, UK.
Dissemination of results
Plain language summaries translated into Bahasa
Malaysia will be distributed through subsector public
health clinics. Community meetings will be held in the
study districts to inform community members/partici-
pants. Relevant state and national Malaysian Ministry of
Health bodies will be provided with reports and publica-
tions in a prompt manner.
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